EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer

Wolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, Manfred Welslau, Volkmar Müller, Florian Schütz, Peter A Fasching, Christian Jackisch, Frederik Marme, Manuel Hörner, Katharina Keller und 19 weitere

Geburtshilfe und Frauenheilkunde · 01.05.2025 · 85 (05) · 493-506

DOI: 10.1055/a-2533-2783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.05.2025. Verfasst von Wolfgang Janni und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review summarizes the latest developments for the treatment of patients with early-stage breast cancer. Most of the clinically relevant changes were the result of using immune checkpoint inhibitors to treat patients with triple-negative breast cancer (TNBC) and CDK4/6 inhibitors to treat patients with hormone receptor-positive, HER2-negative (HRpos/HER2neg) tumors and a high risk of recurrence. Recent studies are presenting more and more data with long follow-up times and integrating translational analyses to evaluate new biomarkers such as circulating tumor DNA (ctDNA). This review article summarizes the latest developments published in recent months and puts the findings in context.

Schlagwörter

Stichwörter der Autor:innen

biomarkerbreast cancerclinical studiesearly breast cancer

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
  • Department of Gynecology and Obstetrics, Marienhospital Bottrop, Bottrop, Germany.
  • Department of Gynecology and Obstetrics, Tübingen University Hospital, Tübingen, Germany.
  • Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Center for Integrated Oncology (CIO Aachen, Bonn, Cologne, Düsseldorf), Düsseldorf, Germany.
  • Onkologie Aschaffenburg, Aschaffenburg, Germany.

Zitieren

APA

Janni, W., Kolberg, H. C., Hartkopf, A. D., Fehm, T. N., Welslau, M., Müller, V., Schütz, F., Fasching, P. A., Jackisch, C., Marme, F., Hörner, M., Keller, K., Goossens, C., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., …, & Radosa, J. C. (2025). Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 85(05), 493-506. https://doi.org/10.1055/a-2533-2783

Vancouver

Janni W, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Müller V, et al. Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde. 2025;85(05):493-506. doi:10.1055/a-2533-2783

BibTeX
@article{Janni2025,
  author = {Janni, Wolfgang and Kolberg, Hans-Christian and Hartkopf, Andreas D and Fehm, Tanja N and Welslau, Manfred and Müller, Volkmar and Schütz, Florian and Fasching, Peter A and Jackisch, Christian and Marme, Frederik and Hörner, Manuel and Keller, Katharina and Goossens, Chloë and Belleville, Erik and Untch, Michael and Thill, Marc and Tesch, Hans and Ditsch, Nina and Lux, Michael P and Banys-Paluchowski, Maggie and Wöckel, Achim and Harbeck, Nadia and Stickeler, Elmar and Bartsch, Rupert and Aktas, Bahriye and Schneeweiss, Andreas and Ettl, Johannes and Taran, Florin-Andrei and Lüftner, Diana and Würstlein, Rachel and Radosa, Julia C},
  title = {Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2025},
  volume = {85},
  number = {05},
  pages = {493--506},
  doi = {10.1055/a-2533-2783}
}
Kostenlos starten →